Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 50090-5772

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 50090-5772). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (5cbe5633 F7a5 4357 Bb0d Ee421bd71c50 01)

Image (5cbe5633 F7a5 4357 Bb0d Ee421bd71c50 01)
Chemical structure diagram of Cyclobenzaprine hydrochloride showing its molecular framework including rings and side chains alongside the hydrochloride component.*
FDA Label Image

Image (5cbe5633 F7a5 4357 Bb0d Ee421bd71c50 02)

FDA Label Image

Label Image (Lbl500905772)

Label Image (Lbl500905772)
Packaging label for Cyclobenzaprine Hydrochloride 10 mg film-coated tablets by A-S Medication Solutions. The label shows the product name, strength, dosage form, quantity of 15 tablets, NDC 50090-5772-0, and storage instructions. It includes regulatory warnings about federal law and prescription use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.